Red man syndrome is seen with
**Core Concept**
Red man syndrome is a cutaneous adverse reaction associated with rapid administration of certain medications, particularly vancomycin. It is characterized by flushing, erythema, and urticaria, often accompanied by pruritus and, in severe cases, hypotension. The pathophysiology involves histamine release and vasodilation.
**Why the Correct Answer is Right**
Vancomycin is a glycopeptide antibiotic that can cause histamine release from mast cells, leading to the characteristic symptoms of red man syndrome. The rapid infusion of vancomycin triggers mast cell degranulation, releasing histamine and other mediators, which cause vasodilation and increased vascular permeability, resulting in the cutaneous manifestations. The syndrome is more common with rapid infusions and can be prevented or treated with slower infusion rates or co-administration of antihistamines.
**Why Each Wrong Option is Incorrect**
**Option A:** This is incorrect because red man syndrome is not typically associated with beta-lactam antibiotics, such as penicillins or cephalosporins. These antibiotics have a different mechanism of action and are less likely to cause histamine release.
**Option B:** This is incorrect because piperacillin-tazobactam is a beta-lactam antibiotic combination that is not commonly associated with red man syndrome. While it can cause allergic reactions, the syndrome is more closely linked to glycopeptide antibiotics like vancomycin.
**Option C:** This is incorrect because linezolid is an oxazolidinone antibiotic that is not typically associated with red man syndrome. It has a different mechanism of action and is less likely to cause histamine release.
**Clinical Pearl / High-Yield Fact**
Red man syndrome is a preventable condition that can be avoided by administering vancomycin slowly, over at least 60 minutes, and in conjunction with antihistamines or other medications to mitigate histamine release. This is a critical consideration for healthcare providers when administering vancomycin to patients.
**Correct Answer:** C. Linezolid.